CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Manufacturing, Design and Contract Revenue	$ 39,103	$ 64,595
Operating Costs and Expenses
Amortization of patents and proprietary technology		6,822
Cost of revenue	8,169	10,793
Administrative and marketing expense	170,391	123,926
Research and development expense	76,799	79,152
Total Operating Costs and Expenses	255,359	220,693
Loss from Operations	(216,256)	(156,098)
Other Income and Expenses
Interest expense	(38,639)	(76,199)
Interest income	232	12
Loss on change in fair value of derivative liabilities		(34,537)
Net Other Expense	(38,407)	(110,724)
Net Loss	$ (254,663)	$ (266,822)
Basic and Diluted Loss per Common Share	$ (0.00)	$ (0.00)
Basic and Diluted Weighted Average Common Shares Outstanding	99,713,464	92,863,464